Literature DB >> 18571587

Factors contributing to negative parathyroid localization: an analysis of 1000 patients.

Eren Berber1, Rikesh T Parikh, Naveen Ballem, Carolyn N Garner, Mira Milas, Allan E Siperstein.   

Abstract

BACKGROUND: Localizing studies are the key for determining the optimal surgical strategy in patients with primary hyperparathyroidism (HP). Most of the data in the literature are retrospective in nature and from analysis on a per patient basis. This is a prospective study looking at the characteristics of the patient and the gland that determine the likelihood of an abnormal parathyroid to be detected by ultrasonography (US) and sestamibi scan (MIBI).
METHODS: This is a prospective analysis of 1000 consecutive patients with HP who underwent parathyroidectomy at a tertiary care center. The study group included HP with single gland disease (63%), double adenoma (15%), as well as hyperplasia (15%), familial HP (2%), and secondary/tertiary HP (6%). All patients underwent surgeon-performed neck US followed by MIBI scan. Univariate logistic regression and multivariate analyses were performed on pre- and intraoperative variables.
RESULTS: A total of 1845 abnormal glands were analyzed. Overall, US was superior to MIBI for the detection of abnormal glands in all subgroups. On multivariate analysis, body mass index (BMI), gland size, and gland volume were the statistically significant independent factors predicting detection by both US and MIBI in primary HP. The sensitivity of US was better for single gland disease than for multigland disease in primary HP, but the sensitivity of MIBI was similar in both groups. For a given size, hyperplastic glands in primary HP imaged less well with US and MIBI than in familial or secondary/tertiary HP.
CONCLUSION: This prospective study demonstrates that BMI and gland size independently predict accurate detection of abnormal parathyroid glands by US and MIBI in sporadic primary HP. Understanding the factors that affect the accuracy of parathyroid localization tests will allow the surgeon to develop a successful surgical strategy in a given patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571587     DOI: 10.1016/j.surg.2008.03.019

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  44 in total

1.  Parathyroid four-dimensional computed tomography: evaluation of radiation dose exposure during preoperative localization of parathyroid tumors in primary hyperparathyroidism.

Authors:  Amit Mahajan; Lee F Starker; Monica Ghita; Robert Udelsman; James A Brink; Tobias Carling
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

2.  Feasibility of unilateral parathyroidectomy in patients with primary hyperparathyroidism and negative or discordant localization studies.

Authors:  Pietro Giorgio Calò; Fabio Medas; Giulia Loi; Enrico Erdas; Giuseppe Pisano; Angelo Nicolosi
Journal:  Updates Surg       Date:  2016-01-29

3.  Super-selective venous sampling in conjunction with quickPTH for patients with persistent primary hyperparathyroidism: report of five cases.

Authors:  Oliver Gimm; Lars-Gunnar Arnesson; Pia Olofsson; Olallo Morales; Claes Juhlin
Journal:  Surg Today       Date:  2012-01-26       Impact factor: 2.549

Review 4.  Selective venous sampling for primary hyperparathyroidism: how to perform an examination and interpret the results with reference to thyroid vein anatomy.

Authors:  Takayuki Yamada; Masaya Ikuno; Yasumoto Shinjo; Atsushi Hiroishi; Shoichiro Matsushita; Tsuyoshi Morimoto; Reiko Kumano; Kunihiro Yagihashi; Takuyuki Katabami
Journal:  Jpn J Radiol       Date:  2017-06-21       Impact factor: 2.374

5.  Pre-operative localization of abnormal parathyroid tissue by 99mTc-sestamibi in primary hyperparathyroidism using four-quadrant site analysis: an evaluation of the predictive value of vitamin D deficiency.

Authors:  Yu-Kwang Donovan Tay; Randy Yeh; Jennifer H Kuo; Catherine McManus; James A Lee; John P Bilezikian
Journal:  Endocrine       Date:  2018-02-05       Impact factor: 3.633

6.  Minimally invasive parathyroidectomy without using intraoperative parathyroid hormone monitoring or gamma probe.

Authors:  Aykut Soyder; Mustafa Ünübol; İmran Kurt Ömürlü; Engin Güney; Serdar Özbaş
Journal:  Ulus Cerrahi Derg       Date:  2015-03-01

7.  Does levothyroxine administration impact parathyroid localization?

Authors:  Rachell R Ayers; Kirby Tobin; Rebecca S Sippel; Courtney Balentine; Dawn Elfenbein; Herbert Chen; David F Schneider
Journal:  J Surg Res       Date:  2015-03-31       Impact factor: 2.192

8.  Neurocognitive dysfunction: a predictor of parathyroid hyperplasia.

Authors:  Daniel Repplinger; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

9.  Actual role of color-doppler high-resolution neck ultrasonography in primary hyperparathyroidism: a clinical review and an observational study with a comparison of 99mTc-sestamibi parathyroid scintigraphy.

Authors:  Giovanni Mariano Vitetta; Alberto Ravera; Giovanni Mensa; Luca Fuso; Pierluigi Neri; Alessandro Carriero; Stefano Cirillo
Journal:  J Ultrasound       Date:  2018-10-24

10.  Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?

Authors:  Anita Skandarajah; Anne Barlier; Nathalie Morlet-Barlat; Frederic Sebag; Alain Enjalbert; Bernard Conte-Devolx; Jean-François Henry
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.